GlassScriptPhysician profile
Prabhtej Brara
NPI 1215917752
$19,235.53
in general payments reported to CMS, 2019-2025
45 companies · $2,378 in 2025
The $2,378 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,284 · 2020: $1,639 · 2021: $2,970 · 2022: $2,952 · 2023: $3,229 · 2024: $2,784 · 2025: $2,378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,391.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,096.74 | 2019-2025 | Avvigo Guidance System, Lux-Dx Insertable Cardiac Monitor, Varithena Administration Pack |
| E.R. Squibb & Sons, L.L.C. | $1,905.42 | 2019-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $1,820.66 | 2019-2025 | Jot Dx, Aveir |
| Novartis Pharmaceuticals Corporation | $1,678.91 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $1,641.33 | 2019-2024 | Xarelto |
| Amgen INC. | $1,098.45 | 2019-2025 | Repatha, Repatha |
| Shockwave Medical, INC | $883.47 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $847.55 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $685.65 | 2019-2024 | |
| Medtronic, INC. | $535.35 | 2021-2023 | Onyx Frontier |
| Merck Sharp & Dohme LLC | $480.84 | 2021-2025 | Verquvo |
| Philips North America LLC | $471.96 | 2019-2024 | (Br3) Coronary Other, (Cm9) Amb Mon & Diag Und |
| Bard Peripheral Vascular, INC. | $412.21 | 2021-2023 | Venclose Maven Catheter |
| Esperion Therapeutics, INC. | $368.49 | 2020-2024 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $339.41 | 2019-2025 | Wainua |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $336.52 | 2019-2025 | Amvuttra, Onpattro |
| Edwards Lifesciences Corporation | $307.54 | 2019-2021 | |
| Abiomed | $256.07 | 2021-2025 | Impella |
| Gilead Sciences, INC. | $240.71 | 2019-2024 | Descovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $230.42 | 2023-2025 | Jardiance |
| Irhythm Technologies, INC. | $227.71 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Heartflow, INC. | $210.28 | 2023-2025 | Ffrct |
| Biotronik INC. | $201.43 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $191.88 | 2019-2025 | Evkeeza |
| Bayer Healthcare Pharmaceuticals INC. | $184.20 | 2024-2025 | |
| Kiniksa Pharmaceuticals, LTD. | $155.99 | 2021-2023 | Arcalyst |
| Kiniksa Pharmaceuticals International, Plc | $147.65 | 2024 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $147.64 | 2021-2023 | Opsumit, Uptravi |
| Surmodics, INC. | $144.92 | 2022 | |
| Medtronic Vascular, INC. | $131.28 | 2019-2020 | |
| Chiesi USA, INC. | $128.56 | 2020-2021 | |
| Cardiva Medical, INC. | $103.60 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Lexicon Pharmaceuticals, INC. | $95.52 | 2023-2024 | Inpefa |
| Bridgebio Pharma, INC. | $84.97 | 2025 | Attruby |
| Impulse Dynamics (USA) INC. | $83.54 | 2023-2024 | Optimizer, Optimizer |
| Biosense Webster, INC. | $67.99 | 2021-2023 | Carto 3 |
| Cardiovascular Systems INC. | $57.20 | 2021 | |
| Lilly USA, LLC | $45.67 | 2025 | Zepbound |
| Bsn Medical INC | $45.39 | 2022-2025 | |
| Arbor Pharmaceuticals, INC. | $42.76 | 2020-2021 | |
| Kestra Medical Technology Services, INC. | $26.30 | 2022 | |
| Novo Nordisk INC | $23.23 | 2022 | |
| Bardy Diagnostics, INC. | $22.74 | 2020 | |
| Azurity Pharmaceuticals, INC. | $22.69 | 2024 | Edarbi |
| Venclose INC. | $4.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prabhtej Brara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.